The New York Times' coverage of the so-called "opioid crisis" (1) has been generally dreadful, but I was still surprised with a new article by Gina Kolata - the paper's science reporter - entitled "
News and analysis on drug development, clinical evidence, regulatory approvals, pharmacology, and the science behind treatments — from small molecules to biologics.
